Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose

No abstract is available for this paper.

• Publication year

  2013

• Venue

  BMJ Case Reports

• Publication date

  2013-01-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bcr-2012-007402PMID 23334490PMCID PMC3604019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of Methylene Blue in the Treatment of Refractory Vasodilatory Shock After Cardiac Assist Device Implantation: Report of Four Consecutive Cases

  2012cited by this paper
• Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1.

  2011cited by this paper
• cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action

  2010cited by this paper
• Methylene Blue: Revisited

  2010cited by this paper
• Amlodipine Increases Endothelial Nitric Oxide by Dual Mechanisms

  2003cited by this paper
• Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass.

  2000cited by this paper
• Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock

  1995cited by this paper
• Inhibition of nitric oxide synthesis by methylene blue.

  1993cited by this paper
• Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.

  1992cited by this paper
• Goodman & Gilman's The Pharmacological Basis of Therapeutics

  1985cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper

• Amlodipine and Losartan Overdose Presenting with Refractory Vasodilatory Shock and Acute Kidney Injury: A Case Report

  2025cites this paper
• Fifty shades of green and blue: autopsy findings after administration of xenobiotics

  2024cites this paper
• Our Treatment Experience in Poisoning With Calcium Channel Blockers: A Series of Twelve Cases

  2024cites this paper
• Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report

  2023cites this paper
• The role of methylene blue in the management of vasoplegic syndrome: a narrative review

  2022cites this paper
• Methylene blue: a controversial diagnostic acid and medication?

  2022cites this paper
• “Feeling the Blues”: A Case of Calcium Channel Blocker Overdose Managed With Methylene Blue

  2021cites this paper
• Treatment for beta-blocker poisoning: a systematic review

  2020cites this paper
• Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning

  2020cites this paper
• Efficacy of methylene blue in a murine model of amlodipine overdose.

  2020cites this paper
• Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review

  2020cites this paper
• Management of Beta Blocker and Calcium Channel Blocker Toxicity

  2020cites this paper
• Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.

  2020cites this paper
• Life-Threatening Serotonin Syndrome Due to Methylene Blue-Citalopram Interaction.

  2019cites this paper
• Hemodynamic improvement using methylene blue after calcium channel blocker overdose.

  2019cites this paper
• Development and Feasibility of a Porcine Model of Amlodipine Toxicity

  2019cites this paper
• Extracorporeal therapy for amlodipine poisoning

  2019cites this paper
• Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.

  2019cites this paper
• Critical Management of Severe Hypotension Caused by Amlodipine Toxicity Managed With Hyperinsulinemia/Euglycemia Therapy Supplemented With Calcium Gluconate, Intravenous Glucagon and Other Vasopressor Support: Review of Literature

  2018influential citation
• Pharmacological and mechanical management of calcium channel blocker toxicity

  2018cites this paper
• A Case of Severe, Refractory Hypotension After Amlodipine Overdose

  2018cites this paper
• Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults

  2017cites this paper
• Are vasopressors useful in toxin-induced cardiogenic shock?

  2017cites this paper
• Management of Calcium Channel Blocker Poisoning

  2017cites this paper
• Therapeutic approach to the critically poisoned patient

  2017cites this paper
• A systematic analysis of methylene blue for drug-induced shock

  2016cites this paper
• Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies.

  2016cites this paper
• 61 : Calcium Channel Blockers

  2016cites this paper
• Comparison of Effects of Separate and Combined Sugammadex and Lipid Emulsion Administration on Hemodynamic Parameters and Survival in a Rat Model of Verapamil Toxicity

  2016cites this paper
• H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores

  2015cites this paper
• A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy

  2015cites this paper
• Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock.

  2015cites this paper
• Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report

  2015cites this paper
• A multifaceted approach to calcium channel blocker overdose: a case report and literature review

  2015cites this paper
• Cardiovascular Toxicity of Cardiovascular Drugs

  2015cites this paper
• Treatment for calcium channel blocker poisoning: A systematic review

  2014cites this paper
• Emergency department management of calcium-channel blocker, beta blocker, and digoxin toxicity.

  2014cites this paper
• Methylene blue used in the treatment of refractory shock resulting from drug poisoning

  2014cites this paper
• Feeling blue with metformin-associated lactic acidosis

  2013cites this paper